CDMRP Ovarian Cancer Research Program Clinical Translational Research Award
ArchivedDefense Health Agency Contracting Activity - DHACA
Description
The Clinical Translational Research Award is intended to support correlative studies that are associated with a clinical trial. The translational research should address high-impact or unmet needs in ovarian cancer. Applications focused on the following OCRP priority are encouraged to apply: Utilize precision medicine and computational approaches that identify individual tumor characteristics and predictive biomarkers across diverse groups to optimize patient care and outcomes. Although not intended to fund the operational aspects of clinical trials, this award supports research projects related to or associated with planned, ongoing, or completed clinical trials supported by other funding sources. Projects that develop clinical endpoints for clinical trials are also encouraged. The application must demonstrate availability and accessibility of the appropriate human subject population, specimens, or human-based resources. The application should also provide a detailed statistical analysis plan that includes a power analysis reflecting sample size projections that will allow a meaningful outcome. Preclinical studies in animals are not allowed.
Who can apply
- Unrestricted
Contact
CDMRP Help Desk <br/>Phone: (301)-682-5507 <br/>Email: help@eBRAP.org
help@eBRAP.org
- PostedFeb 27, 2020
- ClosesJul 30, 2020
- Program funding$3,600,000
- Expected awards5
- CFDA12.420
Pro insight
Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.
Unlock with Pro